These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 20583848

  • 1. Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.
    Archer DF.
    Drugs Aging; 2010 Jul 01; 27(7):533-44. PubMed ID: 20583848
    [Abstract] [Full Text] [Related]

  • 2. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S, Komm BS.
    Maturitas; 2013 Nov 01; 76(3):213-20. PubMed ID: 23849704
    [Abstract] [Full Text] [Related]

  • 3. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS, Mirkin S, Jenkins SN.
    Steroids; 2014 Nov 01; 90():71-81. PubMed ID: 24929044
    [Abstract] [Full Text] [Related]

  • 4. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ, Gillespie JA.
    Postgrad Med; 2017 Apr 01; 129(3):340-351. PubMed ID: 28132583
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bazedoxifene/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women.
    Palacios S, Mejía Ríos A.
    Drugs Today (Barc); 2015 Feb 01; 51(2):107-16. PubMed ID: 25756066
    [Abstract] [Full Text] [Related]

  • 11. Advances in menopausal therapy: the tissue-selective estrogen complex.
    Moore A.
    J Am Assoc Nurse Pract; 2013 Mar 01; 25(3):126-33. PubMed ID: 24218199
    [Abstract] [Full Text] [Related]

  • 12. The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms.
    Kagan R.
    J Womens Health (Larchmt); 2012 Sep 01; 21(9):975-81. PubMed ID: 22759213
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE).
    Lindsay R.
    Osteoporos Int; 2011 Feb 01; 22(2):447-51. PubMed ID: 21069294
    [Abstract] [Full Text] [Related]

  • 15. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S, Currie H, Mikkola TS, Dragon E.
    Maturitas; 2015 Apr 01; 80(4):435-40. PubMed ID: 25684082
    [Abstract] [Full Text] [Related]

  • 16. Use of SERMs for treatment in postmenopausal women.
    Pinkerton JV, Thomas S.
    J Steroid Biochem Mol Biol; 2014 Jul 01; 142():142-54. PubMed ID: 24373794
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
    Lobo RA, Pinkerton JV, Gass MLS, Dorin MH, Ronkin S, Pickar JH, Constantine G.
    Fertil Steril; 2009 Sep 01; 92(3):1025-1038. PubMed ID: 19635615
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. What do TSECs provide in the menopausal hormone therapy?
    Llaneza P, Calaf J, Jurado AR, Mendoza N, Otero B, Quereda F, Sánchez-Borrego R, Lubian D.
    Gynecol Endocrinol; 2018 Oct 01; 34(10):826-832. PubMed ID: 29790381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.